The study was supported by the Bill and Melinda Gates Foundation, GlaxoSmithKline and others. The Icahn School of Medicine at Mount Sinai has issued patents and filed patent applications covering the use of chimeric hemagglutinin antigens as vaccines, and several authors are named as inventors on these.
Pages: 1 2 3 | Single Page
No Responses to “First-in-human Study Has Good News for Universal Flu Vaccine”